Athelas

Athelas is a healthcare technology company that develops medical devices and software solutions to improve patient care and outcomes. Their primary product, the Athelas Home, is an FDA-cleared in-home blood diagnostic device that allows patients to remotely monitor their immune system and key hematological parameters from a single drop of blood.

Key features:
- Remote Monitoring: Enables patients to track their immune system and hematological parameters from home.
- Advanced Analysis: Uses optical imaging and AI-powered analysis to measure white blood cells, neutrophils, platelets, hemoglobin, and other key biomarkers.
- Early Detection: Facilitates early identification of conditions such as infections, leukemia, and neutropenia.
- Proactive Intervention: Allows clinicians to intervene early based on real-time patient data.

How it works:
1. Patient collects a drop of blood using the Athelas Home device.
2. The device uses optical imaging to capture blood sample data.
3. AI-powered analysis processes the data to measure key biomarkers.
4. Results are transmitted to healthcare providers for review and action.

Additional Products:
- Athelas Scribe: An AI-powered medical scribe that integrates with electronic health record (EHR) systems to automate clinical documentation.
- Athelas RCM: A revenue cycle management service providing end-to-end billing and collections support, along with data-driven insights for healthcare practices.

Use of AI:
Athelas employs AI in its Home device for blood sample analysis and in its Scribe product for generating clinical notes and summaries. The company leverages advanced language models and computer vision technologies to process and interpret medical data.

Target users:
- Patients with chronic conditions requiring remote monitoring
- Oncologists and clinicians treating immunosuppressed patients
- Healthcare practices seeking to optimize revenue cycle and clinical documentation processes

How to access:
The Athelas Home device is available for purchase by healthcare providers and patients. Athelas Scribe and RCM services are offered on a subscription basis. Pricing information is not publicly available.

Company Information:
Athelas is headquartered in Mountain View, California, and has raised $151 million in funding from various investors. The Athelas Home device received FDA clearance for home use in 2022.